Christelle Tesson a, Christine Brefel-Courbon b, Jean-Christophe Corvol a, c, Suzanne Lesage a, Alexis Brice a, d 
on behalf of the French Parkinson’s Disease Genetics Study Group†
Yves Agid, Mathieu Anheim, A.-M. Bonnet, Michel Borg, Christine Brefel-Courbon, Alexis Brice, Emmanuel Broussolle, Jean-Christophe Corvol, Philippe Damier, Alain Destée, Alexandra Dürr, Franck Durif, Suzanne Lesage, Ebba Lohmann, Maria Martinez, Pierre Pollak, Olivier Rascol, François Tison, Christine Tranchant, Marc Vérin, François Viallet, Marie Vidailhet
a Inserm U1127, CNRS UMR 7225, UPMC Paris 06 University, UMR S1127, Sorbonne University, Brain and Spinal Cord Institute (ICM), Hôpital de la Salpêtrière, Paris, France
b Toulouse Neuroimaging Centre, UMR 1214, Department of Clinical and Medical Pharmacology, Faculty of Medicine, University of Toulouse, Toulouse, France
c Pitié Neurosciences Clinical Investigation Centre CIC-1422, Paris, France
d Department of Genetics, Pitié-Salpêtrière Hospital Group, GHPS, Public Hospitals of Paris, AP-HP, Paris, France